Nemes Rush Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Nemes Rush Group’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-136	Closed	-$44.3K	–	801
2024 Q3	$44.3K	Buy	+136	New	+$44.3K	0.01%	269
2024 Q2	–	Sell	-136	Closed	-$44.3K	–	698
2024 Q1	$44.3K	Hold	136	–	–	0.01%	287
2023 Q4	$25.9K	Hold	136	–	–	﹤0.01%	324
2023 Q3	$27.1K	Hold	136	–	–	﹤0.01%	309
2023 Q2	$38.8K	Buy	+136	New	+$37.8K	0.01%	295

Nemes Rush Group's SWAV Position: Q4 2024 in Review

Nemes Rush Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2024, closing a stake of 136 shares — an estimated $44.3K sold.

Nemes Rush Group first reported a position in SWAV in Q2 2023 and held it in 5 quarters. The position peaked at $44.3K in Q3 2024. 0 funds tracked by Wall St. Rank hold SWAV as of Q4 2024.

Nemes Rush Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Nemes Rush Group sold 136 Shockwave Medical, Inc. Common Stock shares in Q4 2024, an estimated $44.3K.
Nemes Rush Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
Nemes Rush Group's Shockwave Medical, Inc. Common Stock position peaked at $44.3K in Q3 2024.
0 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2024.

Based on Nemes Rush Group's 13F filing for Q4 2024, filed 12 Feb 2025.